Latest 10-Q quarterly reports

Azenta, Inc. reported its Q2 2026 financial results, showing a slight revenue increase but a significant net loss driven by a $149.1 million goodwill impairment charge.

Tredegar Corporation reported a significant increase in net income from continuing operations for Q1 2026, driven by strong performance in its Aluminum Extrusions segment.

SIFCO Industries saw a significant revenue increase in Q2 2026, driven by strong military program demand, leading to a substantial improvement in profitability.

Clover Health Investments, Corp. announced a significant turnaround in its Q1 2026 financial performance, reporting a net income of $27.3 million compared to a net loss in the prior year.

GraniteShares Gold Trust reports a 6.8% increase in net asset value for Q3 2026, driven by a 6.97% rise in gold prices.

Telephone and Data Systems, Inc. (TDS) reported a significant increase in net income for Q1 2026, largely due to substantial gains from the divestiture of Array's wireless operations and spectrum licenses.

Array Digital Infrastructure reports a significant 93% increase in total operating revenues for Q1 2026, driven by tower rental growth and spectrum asset sales, while navigating a proposed acquisition by TDS.

Alpha Metallurgical Resources reported a net loss for Q1 2026, but saw improvements in operational costs and coal margins, alongside a significant increase in Adjusted EBITDA.

GraniteShares Platinum Trust reports significant growth in net assets and platinum holdings for the nine months ended March 31, 2026, driven by a substantial increase in platinum prices.

Ultralife Corporation reported a 6.5% decrease in revenue for the first quarter of 2026 compared to the prior year, driven by declines in both commercial and government/defense sales.

Cognition Therapeutics reports a reduced net loss for Q1 2026, driven by lower R&D expenses, while continuing development of its lead drug candidate, zervimesine.

Marten Transport reports a significant decrease in net income for Q1 2026, driven by lower operating revenue across key segments, particularly Dedicated and Intermodal.

Oportun Financial Corporation reported a decrease in total revenue and net income for the first quarter of 2026 compared to the same period in 2025.

Tvardi Therapeutics reported a wider net loss for Q1 2026 driven by increased R&D spending, while cash reserves remain a concern.

Treace Medical Concepts reported a 10.2% revenue decrease in Q1 2026 compared to the prior year, driven by a shift from higher-priced Lapiplasty systems to lower-priced minimally invasive alternatives.

Boundless Bio reports Q1 2026 results, detailing a net loss of $13.6 million, a strategic focus on BBI-940, and a significant lease termination and restructuring.

Kiora Pharmaceuticals reports a net loss of $2.42 million for Q1 2026, with cash reserves projected to fund operations into late 2028 following a recent financing.

Enbridge Inc. reports Q1 2026 results with lower earnings attributable to common shareholders, primarily due to derivative fair value losses, though operational performance in Gas Transmission and Gas Distribution segments shows strength.

News Corporation reported a 9% increase in Q3 revenue driven by digital real estate and Dow Jones, but net income attributable to stockholders decreased by 14% year-over-year.

Somnigroup International Inc. announced a significant increase in net sales and operating income for the first quarter of 2026, driven by the full inclusion of Mattress Firm and improved margins.

Burford Capital Limited announced a substantial net loss for the first quarter of 2026, primarily driven by a significant write-down related to the YPF Judgment Reversal.

DraftKings Inc. announced its first quarter 2026 financial results, showcasing a significant increase in revenue and a return to profitability.

RE/MAX Holdings reported a net loss of $9.7 million for Q1 2026, with total revenue down 5.7% year-over-year, while progressing towards its acquisition by The Real Brokerage Inc.

Ubiquiti Inc. announced robust financial performance for the third quarter of fiscal year 2026, with significant revenue growth driven by its Enterprise Technology segment.

ANI Pharmaceuticals announces a 20.5% increase in net revenues for Q1 2026, driven by its Rare Disease and Brands segment, with significant growth in Cortrophin Gel and ILUVIEN sales.

Starwood Property Trust reported a decrease in net income for Q1 2026 compared to the prior year, driven by shifts in loan portfolio performance and derivative valuations.

HA Sustainable Infrastructure Capital, Inc. reports a net loss of $73.7 million for Q1 2026, a significant shift from the prior year's profit, driven by increased expenses and lower equity method investment income.

Matador Resources Company announced a net loss for the first quarter of 2026, primarily driven by significant unrealized losses on derivative instruments, despite an increase in oil production.

Artiva Biotherapeutics announces positive initial clinical data for AlloNK in autoimmune diseases, with a planned Phase 3 trial in refractory RA.

Cross Country Healthcare, Inc. reported a net loss of $4.3 million for Q1 2026, with revenues down 17.8% year-over-year, alongside the announcement of a definitive merger agreement.